Betagenon AB
Thulegatan 1a, 903 26 Umea, Sweden
About the sponsor
Betagenon AB’s clinical research is centred on obesity and related metabolic conditions, with studies addressing prediabetes and type 2 diabetes mellitus. The sponsor’s focus includes populations with excess body weight as well as individuals with metabolic risk factors linked to impaired glucose regulation.
- Obesity with prediabetes
- Obesity and type 2 diabetes mellitus
- Overweight and healthy subjects
The research portfolio reflects interest in therapeutic approaches relevant to body-weight reduction and metabolic control.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.
